Immunoliposomal form of simvastatin - an attempt to use in the treatment of EGFR-dependent tumors.
2016/21/B/NZ7/01070
Keywords
Descriptors
- NZ7_14: Farmacja, farmakoterapia, farmakologia
- NZ5_7: Leczenie chorób człowieka
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Wrocławski, Wydział Biotechnologii
Voivodeship: dolnośląskie
Principal investigator (from the host institution)
prof. Aleksander Franciszek Sikorski
Number of co-investigators in the project: 3
Call
OPUS 11 – announced on 2016-03-15
- Amount awarded
- 387 400 PLN
- Project start date
- 2017-01-18
- Project end date
- 2019-04-17
- Project duration
- 27 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (4)
-
Kierowany za pomocą przeciwciał, liposomowy preparat statyny oraz jego zastosowanie
- Authors:
- Lucyna Matusewicz, Aleksander F. Sikorski
- Academic press:
- Biuletyn Urzędu Patentowego (year: 2019, volume: 23/2019, pages: 6, 425432 udzielony patent Pat.236106), Publisher: URZĄD PATENTOWY RZECZYPOSPOLITEJ POLSKIEJ
- Status:
- Published
-
Attempts to use statins in cancertherapy: An update
- Authors:
- Lucyna Matusewicz, Aleksander Czogalla and Aleksander F Sikorski
- Academic press:
- Tumor Biology (year: 2020, volume: 42(7), pages: 7), Publisher: SAGE
- Status:
- Published
- DOI:
- 10.1177/1010428320941760.2020 – link to the publication
-
Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro Study.
- Authors:
- Matusewicz L, Podkalicka J, Sikorski AF.
- Academic press:
- Cancers (Basel). (year: 2018, volume: 10(11)., pages: pii: E418.), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cancers10110418. – link to the publication
-
EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers
- Authors:
- Lucyna Matusewicz1, Beata Filip-Psurska2, Mateusz Psurski2, Sabina Tabaczar1, Joanna Podkalicka1, Joanna Wietrzyk2, Piotr Ziółkowski3, Aleksander Czogalla1, Aleksander F. Sikorski1
- Academic press:
- International Journal of Parmaceutics (year: 2019, volume: 569,, pages: 118605), Publisher: Elsevier
- Status:
- Published
- DOI:
- 10.1016/j.ijpharm.2019.118605 – link to the publication
Articles in post-conference publications (2)
-
Liposomes targeted with Therapeutic Antibodies a Lego-block Versatile Tool for Anticancer Therapy.
- Authors:
- Sikorski A.F.
- Conference:
- PCS 4th Annual Global Cancer Conference-2017 and PCS 4th World Congerss of Cardiothoratic-Renal Diseases-2017, Lisbon, (year: 2017, pages: abstr. P.11), Publisher: PCS
- Date:
- conference 4-5.11
- Status:
- Published
-
Simvastatin immunoliposomes as potential therapeutic treatment of EGF receptor family-dependent breast tumors.
- Authors:
- Matusewicz L., Sikorski A.F.
- Conference:
- Liposome Advances, Progress in Drug and Vaccine Delivery. ILS and Liposome research Days Combined Conference (year: 2017, pages: 82), Publisher: ILS
- Date:
- conference 16-17. 09
- Status:
- Published